G Robustelli della Cuna - JoVE Visualize

Showing results (11-20 of 71) with videos related to

Pageof 8

Sort By:

Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|January 5, 2002

153Sm-EDTMP radionuclide treatment of bony metastatic disease: a radiation protection evaluationL Moro, D Fantinato, C Aprile, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1994

Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cellsG Sica, F Iacopino, G Robustelli della Cuna, et al.

Journal of Neuro-Oncology|January 1, 1984

Radio-chemo-immunotherapy (CCNU plus levamisole) for treatment of metastatic brain tumors. A pilot studyG Robustelli della Cuna, L Pavesi, R Knerich, et al.

Bone Marrow Transplantation|August 26, 1998

Control of stem cell proliferation and differentiation to achieve stable gene transfer and expressionF Bertolini, M Battaglia, A Lanza, et al.

Tumori|June 11, 1999

A double-blind evaluation of the analgesic efficacy and toxicity of oral ketorolac and diclofenac in cancer pain. The TD/10 recordati Protocol Study GroupF Pannuti, G Robustelli della Cuna, V Ventaffrida, et al.

Bone Marrow Transplantation|March 2, 1997

A new 'two step' procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantationF Bertolini, T Thomas, M Battaglia, et al.

Minerva Medica|June 8, 1984

[Chemotherapy of malignant brain tumors in childhood]R Knerich, G Butti, S Pezzotta, et al.

Anticancer Research|January 1, 1994

Morphological and biochemical features of a medroxyprogesterone acetate (MPA)-resistant MCF-7 breast cancer cell lineN Gibelli, C Zibera, G Sica, et al.

Minerva Medica|November 10, 1980

[Oral high doses of medroxyprogesterone acetate (MPA) in the treatment of advanced phases of breast and endometrial cancer]M R Bernardo-Strada, E Imparato, G Aspesi, et al.

Anticancer Research|September 3, 1999

Poor outcome of patients with resectable breast cancer receiving adjuvant high-dose sequential chemotherapy following preoperative treatmentA Zambelli, G A Da Prada, P Pedrazzoli, et al.

Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:

Pageof 8

Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|January 5, 2002

153Sm-EDTMP radionuclide treatment of bony metastatic disease: a radiation protection evaluationL Moro, D Fantinato, C Aprile, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1994

Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cellsG Sica, F Iacopino, G Robustelli della Cuna, et al.

Journal of Neuro-Oncology|January 1, 1984

Radio-chemo-immunotherapy (CCNU plus levamisole) for treatment of metastatic brain tumors. A pilot studyG Robustelli della Cuna, L Pavesi, R Knerich, et al.

Bone Marrow Transplantation|August 26, 1998

Control of stem cell proliferation and differentiation to achieve stable gene transfer and expressionF Bertolini, M Battaglia, A Lanza, et al.

Tumori|June 11, 1999

A double-blind evaluation of the analgesic efficacy and toxicity of oral ketorolac and diclofenac in cancer pain. The TD/10 recordati Protocol Study GroupF Pannuti, G Robustelli della Cuna, V Ventaffrida, et al.

Bone Marrow Transplantation|March 2, 1997

A new 'two step' procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantationF Bertolini, T Thomas, M Battaglia, et al.

Minerva Medica|June 8, 1984

[Chemotherapy of malignant brain tumors in childhood]R Knerich, G Butti, S Pezzotta, et al.

Anticancer Research|January 1, 1994

Morphological and biochemical features of a medroxyprogesterone acetate (MPA)-resistant MCF-7 breast cancer cell lineN Gibelli, C Zibera, G Sica, et al.

Minerva Medica|November 10, 1980

[Oral high doses of medroxyprogesterone acetate (MPA) in the treatment of advanced phases of breast and endometrial cancer]M R Bernardo-Strada, E Imparato, G Aspesi, et al.

Anticancer Research|September 3, 1999

Poor outcome of patients with resectable breast cancer receiving adjuvant high-dose sequential chemotherapy following preoperative treatmentA Zambelli, G A Da Prada, P Pedrazzoli, et al.

Pageof 8